Baidu
map

心血管指南

订阅

MedSci主页 / 所有栏目 / 心血管指南

2018 AHA科学声明：右心衰的评估和管理

2018-04-12 美国心脏协会 Circulation. 2018 Apr 12.

右心衰

2018年4月，美国心脏协会(AHA)发布了右心衰的评估和管理的科学声明，右心衰至一种复杂的综合征，包括不同的病因，路径和病理过程，本文主要针回顾了导致右心功能障碍的病因和流行病学，急慢性右心衰的病理以及右心衰的管理指导。

中文标题：

2018 AHA科学声明：右心衰的评估和管理

英文标题：

Evaluation and Management of Right-Sided Heart Failure: A Scientific Statement From the American Heart Association.

发布机构：

美国心脏协会

发布日期：

2018-04-12

简要介绍：

2018年4月，美国心脏协会(AHA)发布了右心衰的评估和管理的科学声明，右心衰至一种复杂的综合征，包括不同的病因，路径和病理过程，本文主要针回顾了导致右心功能障碍的病因和流行病学，急慢性右心衰的病理以及右心衰的管理指导。

 

拓展指南：与心衰相关指南：

相关资料下载：
[AttachmentFileName(sort=100, fileName=2018 AHA科学声明：右心衰的评估和管理)] GetToolGuiderByIdResponse(projectId=1, id=f124c1c001580e21, title=2018 AHA科学声明：右心衰的评估和管理, enTitle=Evaluation and Management of Right-Sided Heart Failure: A Scientific Statement From the American Heart Association., guiderFrom=Circulation. 2018 Apr 12., authorId=null, author=, summary=2018年4月，美国心脏协会(AHA)发布了右心衰的评估和管理的科学声明，右心衰至一种复杂的综合征，包括不同的病因，路径和病理过程，本文主要针回顾了导致右心功能障碍的病因和流行病学，急慢性右心衰的病理以及右心衰的管理指导。 , cover=, journalId=null, articlesId=null, associationId=60, associationName=美国心脏协会, associationIntro=美国心脏协会（AHA，American Heart Association）是心脏病学领域比较正要的学会之一，致力于心脏病和卒中的预防与治疗，提供相关继续教育、流行病学年度报告。每年举办学术年会报道中的的临床试验结果等，有官方杂志《美国心脏协会杂志》，提供心血管疾病和卒中相关的指南及专家共识，更新的比较快。, copyright=0, guiderPublishedTime=Thu Apr 12 00:00:00 CST 2018, originalUrl=, linkOutUrl=, content=<P>2018年4月，美国心脏协会(AHA)发布了右心衰的评估和管理的科学声明，右心衰至一种复杂的综合征，包括不同的病因，路径和病理过程，本文主要针回顾了导致右心功能障碍的病因和流行病学，急慢性右心衰的病理以及右心衰的管理指导。 </P> <P> </P>拓展指南：<strong>与<font color=red>心衰</font>相关指南：</strong><br><ul><li><a href="//www.sandwebs.com/guideline/show_article.do?id=a82c61c00156e0c7" title="2018 HFA/ESC立场声明：2型糖尿病和心衰" target=_blank>2018 HFA/ESC立场声明：2型糖尿病和心衰</a></li> <li><a href="//www.sandwebs.com/guideline/show_article.do?id=13a191c0015ae861" title="《生物标志物在心衰预防、评估以及管理中的作用》解读" target=_blank>《生物标志物在心衰预防、评估以及管理中的作用》解读</a></li> <li><a href="//www.sandwebs.com/guideline/show_article.do?id=f2b191c0015386d2" title="2017 ACC专家共识：优化心衰治疗的决策路径" target=_blank>2017 ACC专家共识：优化心衰治疗的决策路径</a></li> <li><a href="//www.sandwebs.com/guideline/show_article.do?id=8896f1c001532287" title="2017 EPCCS实践指南：基层医疗中心衰的诊断和管理" target=_blank>2017 EPCCS实践指南：基层医疗中心衰的诊断和管理</a></li> <li><a href="//www.sandwebs.com/guideline/show_article.do?id=049811c001a249d3" title="2017 AHA科学声明：生物标志物在心衰预防，评估以及管理中的作用" target=_blank>2017 AHA科学声明：生物标志物在心衰预防，评估以及管理中的作用</a></li> 更多信息请点击：<a href="//www.sandwebs.com/guideline/list.do?q=%E5%BF%83%E8%A1%B0" target=_blank>有关心衰更多指南</a></ul>, tagList=[TagDto(tagId=61548, tagName=右心衰)], categoryList=[CategoryDto(categoryId=2, categoryName=心血管, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=null, articleKeyword=null, articleKeywordNum=null, guiderKeywordId=null, guiderKeyword=null, guiderKeywordNum=null, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=其他, guiderLanguage=0, guiderRegion=1, opened=0, paymentType=null, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=7560, appHits=584, showAppHits=0, pcHits=5865, showPcHits=1623, likes=127, shares=29, comments=8, approvalStatus=1, publishedTime=Tue Apr 17 22:50:30 CST 2018, publishedTimeString=2018-04-12, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=1, createdBy=null, createdName=qiushida2, createdTime=Tue Apr 17 22:50:30 CST 2018, updatedBy=null, updatedName=null, updatedTime=Mon Jan 01 22:29:37 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=100, fileName=2018 AHA科学声明：右心衰的评估和管理)])
2018 AHA科学声明：右心衰的评估和管理
下载请点击：
评论区 (7)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=905425, encodeId=130e9054250b, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201014/5fd5ad8baf3143eca77599394a5d7814/afa2e4f1fc004849943924c8fa54a20d.jpg, createdBy=fe745425992, createdName=ms1000001905139296, createdTime=Sun Dec 06 16:35:41 CST 2020, time=2020-12-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=883557, encodeId=9edb88355e91, content=右心, beContent=null, objectType=guider, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210524/55f15b58d91d45c09faf0272721b59d8/b8f36c2def38403ab9fdabaae56a939c.jpg, createdBy=f0935399328, createdName=ms1000000302953060, createdTime=Tue Sep 08 10:48:08 CST 2020, time=2020-09-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=316537, encodeId=766b31653ed7, content=好文献学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b5a62240667, createdName=张新亮1853311252142e2fm, createdTime=Sat May 19 07:29:10 CST 2018, time=2018-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=307335, encodeId=1ea830e335c6, content=很前沿, beContent=null, objectType=guider, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/07/28/dc0a622c5c75f55fb8c848c04ece3cdc.jpg, createdBy=916d2333311, createdName=尹乔, createdTime=Thu Apr 19 18:05:55 CST 2018, time=2018-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=306837, encodeId=efe230683e66, content=好文献.学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b5a62240667, createdName=张新亮1853311252142e2fm, createdTime=Wed Apr 18 06:46:35 CST 2018, time=2018-04-18, status=1, ipAttribution=)]
    2020-12-06 ms1000001905139296

    好

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=905425, encodeId=130e9054250b, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201014/5fd5ad8baf3143eca77599394a5d7814/afa2e4f1fc004849943924c8fa54a20d.jpg, createdBy=fe745425992, createdName=ms1000001905139296, createdTime=Sun Dec 06 16:35:41 CST 2020, time=2020-12-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=883557, encodeId=9edb88355e91, content=右心, beContent=null, objectType=guider, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210524/55f15b58d91d45c09faf0272721b59d8/b8f36c2def38403ab9fdabaae56a939c.jpg, createdBy=f0935399328, createdName=ms1000000302953060, createdTime=Tue Sep 08 10:48:08 CST 2020, time=2020-09-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=316537, encodeId=766b31653ed7, content=好文献学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b5a62240667, createdName=张新亮1853311252142e2fm, createdTime=Sat May 19 07:29:10 CST 2018, time=2018-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=307335, encodeId=1ea830e335c6, content=很前沿, beContent=null, objectType=guider, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/07/28/dc0a622c5c75f55fb8c848c04ece3cdc.jpg, createdBy=916d2333311, createdName=尹乔, createdTime=Thu Apr 19 18:05:55 CST 2018, time=2018-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=306837, encodeId=efe230683e66, content=好文献.学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b5a62240667, createdName=张新亮1853311252142e2fm, createdTime=Wed Apr 18 06:46:35 CST 2018, time=2018-04-18, status=1, ipAttribution=)]
    2020-09-08 ms1000000302953060

    右心

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=905425, encodeId=130e9054250b, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201014/5fd5ad8baf3143eca77599394a5d7814/afa2e4f1fc004849943924c8fa54a20d.jpg, createdBy=fe745425992, createdName=ms1000001905139296, createdTime=Sun Dec 06 16:35:41 CST 2020, time=2020-12-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=883557, encodeId=9edb88355e91, content=右心, beContent=null, objectType=guider, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210524/55f15b58d91d45c09faf0272721b59d8/b8f36c2def38403ab9fdabaae56a939c.jpg, createdBy=f0935399328, createdName=ms1000000302953060, createdTime=Tue Sep 08 10:48:08 CST 2020, time=2020-09-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=316537, encodeId=766b31653ed7, content=好文献学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b5a62240667, createdName=张新亮1853311252142e2fm, createdTime=Sat May 19 07:29:10 CST 2018, time=2018-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=307335, encodeId=1ea830e335c6, content=很前沿, beContent=null, objectType=guider, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/07/28/dc0a622c5c75f55fb8c848c04ece3cdc.jpg, createdBy=916d2333311, createdName=尹乔, createdTime=Thu Apr 19 18:05:55 CST 2018, time=2018-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=306837, encodeId=efe230683e66, content=好文献.学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b5a62240667, createdName=张新亮1853311252142e2fm, createdTime=Wed Apr 18 06:46:35 CST 2018, time=2018-04-18, status=1, ipAttribution=)]
    2018-05-19 张新亮1853311252142e2fm

    好文献学习了

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=905425, encodeId=130e9054250b, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201014/5fd5ad8baf3143eca77599394a5d7814/afa2e4f1fc004849943924c8fa54a20d.jpg, createdBy=fe745425992, createdName=ms1000001905139296, createdTime=Sun Dec 06 16:35:41 CST 2020, time=2020-12-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=883557, encodeId=9edb88355e91, content=右心, beContent=null, objectType=guider, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210524/55f15b58d91d45c09faf0272721b59d8/b8f36c2def38403ab9fdabaae56a939c.jpg, createdBy=f0935399328, createdName=ms1000000302953060, createdTime=Tue Sep 08 10:48:08 CST 2020, time=2020-09-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=316537, encodeId=766b31653ed7, content=好文献学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b5a62240667, createdName=张新亮1853311252142e2fm, createdTime=Sat May 19 07:29:10 CST 2018, time=2018-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=307335, encodeId=1ea830e335c6, content=很前沿, beContent=null, objectType=guider, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/07/28/dc0a622c5c75f55fb8c848c04ece3cdc.jpg, createdBy=916d2333311, createdName=尹乔, createdTime=Thu Apr 19 18:05:55 CST 2018, time=2018-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=306837, encodeId=efe230683e66, content=好文献.学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b5a62240667, createdName=张新亮1853311252142e2fm, createdTime=Wed Apr 18 06:46:35 CST 2018, time=2018-04-18, status=1, ipAttribution=)]
    2018-04-19 尹乔

    很前沿

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=905425, encodeId=130e9054250b, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201014/5fd5ad8baf3143eca77599394a5d7814/afa2e4f1fc004849943924c8fa54a20d.jpg, createdBy=fe745425992, createdName=ms1000001905139296, createdTime=Sun Dec 06 16:35:41 CST 2020, time=2020-12-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=883557, encodeId=9edb88355e91, content=右心, beContent=null, objectType=guider, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210524/55f15b58d91d45c09faf0272721b59d8/b8f36c2def38403ab9fdabaae56a939c.jpg, createdBy=f0935399328, createdName=ms1000000302953060, createdTime=Tue Sep 08 10:48:08 CST 2020, time=2020-09-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=316537, encodeId=766b31653ed7, content=好文献学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b5a62240667, createdName=张新亮1853311252142e2fm, createdTime=Sat May 19 07:29:10 CST 2018, time=2018-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=307335, encodeId=1ea830e335c6, content=很前沿, beContent=null, objectType=guider, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/07/28/dc0a622c5c75f55fb8c848c04ece3cdc.jpg, createdBy=916d2333311, createdName=尹乔, createdTime=Thu Apr 19 18:05:55 CST 2018, time=2018-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=306837, encodeId=efe230683e66, content=好文献.学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b5a62240667, createdName=张新亮1853311252142e2fm, createdTime=Wed Apr 18 06:46:35 CST 2018, time=2018-04-18, status=1, ipAttribution=)]
    2018-04-18 张新亮1853311252142e2fm

    好文献.学习了

    0

Baidu
map
Baidu
map
Baidu
map